Actinium reported data from the Phase III SIERRA trial of Iomab-B for relapsed or refractory acute myeloid leukaemia (r/r AML ...

Summit Therapeutics and Akeso published results for the Phase III HARMONi-2 trial, which tested ivonescimab, a bispecific ...

The trial compares Eli Lilly’s lutetium zadavotide guraxetan with Astellas’s Xtandi or Janssen’s Zytiga for mPRPC.

The blinded blood pressure monitor and scale allows blind data monitoring, where participants can take readings but not see ...

Pfizer’s cancer cachexia candidate has provided patients with clinically meaningful weight gain in a Phase II trial, with the ...

The Clinical Trials Arena team investigates assets in infectious diseases, metabolic disorders, oncology and ophthalmology.

Antimicrobial drugs are widely used around the world to treat infections. However, the overuse of antimicrobials has resulted ...

At the Clinical Trial Supply West Coast 2024 conference, serial biotech entrepreneur Umar Hayat said science should be ...

Merit Medical has revealed positive six-month data from a trial investigating its endoprosthesis in dialysis patients who ...

As Ipsen pivots away from Cabometyx in mCRPC, US rights holder Exelixis will press ahead with a submission to the FDA.

Patritumab deruxtecan’s safety profile in the trial was in line with previous lung cancer studies. Credit: Jo Panuwat D/Shutterstock. Daiichi Sankyo and MSD (Merck & Co) have reported that the Phase ...

The trial enrolled 102 patients with metabolic-dysfunction-associated steatohepatitis. Credit: Emily frost / Shutterstock. Aligos Therapeutics has announced positive topline results from the Phase IIa ...